Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kasthuri
    Member
    • Jun 2011
    • 36

    #1

    UnifiedGenotyper between tumor and normal

    I have 8 tumor and normal samples (16 altogether). If I want to compare the SNP's between them (8 Tumor vs 8 Normal), should I run the UnifiedGenotyper separately twice (one run for Tumor samples and another for normal) or can I run them altogether once with 16 sample bam's. What could be the best way to analyze them?

    Thanks.
  • fpepin
    Member
    • Feb 2011
    • 30

    #2
    Are these matched normals or you have 16 individuals in all?

    Running in all together would get you an average of everything, which would be a bad idea. Unless you think that your SNP of interest would be in all tumors, even putting these together would be inadvisable.

    GATK specifically says to be REALLY careful about just running the genotyper and removing the SNPs in the normals. It might be ok if you're looking for a few interesting mutations that you can verify manually, but it's not ideal for large-scale efforts.

    The authors of GATK say that they have their own effort underway, but it's not public yet. I know of another yet-unreleased effort but I don't know of of any publicly available genotyper for tumor-normal pairs.

    Comment

    • kasthuri
      Member
      • Jun 2011
      • 36

      #3
      Thank you fpepin. These are matched normals of 8 pairs. I guess I will run them individually as it is advised.

      Comment

      • pravee1216
        Member
        • Aug 2010
        • 35

        #4
        Running Unified Genotyper on individual samples and identifying true somatic calls would be difficult as you may require a statistical score/probability value and variant_allele_frequency (VAF) to support the calls. I see MuTect is one you may try but the tool is still not available to public. You may also look at VarScan, SomaticSniper, Joint-SNV-mix.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...